{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T10:04:50Z","timestamp":1772013890608,"version":"3.50.1"},"reference-count":39,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:00:00Z","timestamp":1771286400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Background\/Objectives: The use of stereotactic body radiotherapy (SBRT) for centrally and ultra-centrally located early-stage non-small cell lung cancer (NSCLC) remains clinically challenging due to the proximity of critical mediastinal organs at risk and the limited prospective evidence, particularly for ultra-central disease. Real-world data are needed to better define the safety and efficacy of SBRT when delivered according to contemporary protocol-based planning principles. Methods: This retrospective cohort study included patients treated at two radiotherapy centers, with centralized follow-up and outcome adjudication at a single academic institution. We evaluated patients with centrally or ultra-centrally located, early-stage NSCLC treated with SBRT according to dose-fractionation and planning principles derived from the NRG Oncology\/RTOG 0813 protocol. Tumors were classified as central or ultra-central according to the International Association for the Study of Lung Cancer and HILUS definitions, respectively. The prescribed dose was 50 Gy in five fractions. Primary endpoints were treatment-related toxicity and local progression-free survival (LPFS). Secondary endpoints included overall survival (OS), progression-free survival (PFS), and dosimetric outcomes. Survival endpoints were analyzed using the Kaplan\u2013Meier method. Results: Seventy-eight patients were included, of whom 52 had centrally located and 26 ultra-centrally located tumors. Median follow-up was 57 months. The overall objective response rate was 92.3%. The estimated 4-year LPFS was 97.4% for the entire cohort, with rates of 100% for central and 91.6% for ultra-central tumors (p &lt; 0.001). Four-year OS was 98.7%, with no treatment-related deaths observed. Treatment-related toxicity was minimal, with grade \u2265 2 events occurring in only one patient (1.3%) and no grade \u2265 3 toxicity. All treatment plans met predefined organ-at-risk dose constraints. Conclusions: In this real-world cohort, SBRT delivered according to RTOG 0813 planning principles achieved excellent local control with minimal clinically relevant toxicity in patients with centrally and ultra-centrally located early-stage NSCLC. These findings support the safe implementation of SBRT in carefully selected patients when stringent organ-at-risk constraints and conservative treatment planning are employed.<\/jats:p>","DOI":"10.3390\/cancers18040653","type":"journal-article","created":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T13:15:35Z","timestamp":1771334135000},"page":"653","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Real-World Data on the Safety and Efficacy of SBRT for Central and Ultra-Central Lung Tumors: A Retrospective Multi-Center Cohort"],"prefix":"10.3390","volume":"18","author":[{"given":"Anna","family":"Zygogianni","sequence":"first","affiliation":[{"name":"Department of Clinical Radiation Oncology, Medical School, National and Kapodistrian University of Athens, \u201cAttikon\u201d University Hospital, 12462 Haidari, Greece"},{"name":"Center of Radiation Oncology and Stereotactic Radiosurgery, \u201cMediterraneo\u201d General Hospital, 16675 Glyfada, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3576-5495","authenticated-orcid":false,"given":"Andromachi","family":"Kougioumtzopoulou","sequence":"additional","affiliation":[{"name":"Department of Clinical Radiation Oncology, Medical School, National and Kapodistrian University of Athens, \u201cAttikon\u201d University Hospital, 12462 Haidari, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2977-7895","authenticated-orcid":false,"given":"Kalliopi","family":"Platoni","sequence":"additional","affiliation":[{"name":"Center of Radiation Oncology and Stereotactic Radiosurgery, \u201cMediterraneo\u201d General Hospital, 16675 Glyfada, Greece"},{"name":"Laboratory of Applied Medical Physics, Medical School, National and Kapodistrian University of Athens, \u201cAttikon\u201d University Hospital, 12462 Haidari, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Protopapa","sequence":"additional","affiliation":[{"name":"Center of Radiation Oncology and Stereotactic Radiosurgery, \u201cMediterraneo\u201d General Hospital, 16675 Glyfada, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zoi","family":"Liakouli","sequence":"additional","affiliation":[{"name":"Center of Radiation Oncology and Stereotactic Radiosurgery, \u201cMediterraneo\u201d General Hospital, 16675 Glyfada, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ioannis M.","family":"Koukourakis","sequence":"additional","affiliation":[{"name":"Department of Clinical Radiation Oncology, Medical School, National and Kapodistrian University of Athens, \u201cAttikon\u201d University Hospital, 12462 Haidari, Greece"},{"name":"Center of Radiation Oncology and Stereotactic Radiosurgery, \u201cMediterraneo\u201d General Hospital, 16675 Glyfada, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-8211-5381","authenticated-orcid":false,"given":"Despoina","family":"Alexiou","sequence":"additional","affiliation":[{"name":"Center of Radiation Oncology and Stereotactic Radiosurgery, \u201cMediterraneo\u201d General Hospital, 16675 Glyfada, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1992-6447","authenticated-orcid":false,"given":"Theodoros","family":"Stroubinis","sequence":"additional","affiliation":[{"name":"Center of Radiation Oncology and Stereotactic Radiosurgery, \u201cMediterraneo\u201d General Hospital, 16675 Glyfada, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7049-6791","authenticated-orcid":false,"given":"Christina","family":"Armpilia","sequence":"additional","affiliation":[{"name":"1st Department of Radiology, National and Kapodistrian University of Athens, \u201cAretaieion\u201d University Hospital, 11528 Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5456-8337","authenticated-orcid":false,"given":"Christos","family":"Antypas","sequence":"additional","affiliation":[{"name":"1st Department of Radiology, National and Kapodistrian University of Athens, \u201cAretaieion\u201d University Hospital, 11528 Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0515-1070","authenticated-orcid":false,"given":"Michalis","family":"Psarras","sequence":"additional","affiliation":[{"name":"Center of Radiation Oncology and Stereotactic Radiosurgery, \u201cMediterraneo\u201d General Hospital, 16675 Glyfada, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8309-7968","authenticated-orcid":false,"given":"Despoina","family":"Stasinou","sequence":"additional","affiliation":[{"name":"Center of Radiation Oncology and Stereotactic Radiosurgery, \u201cMediterraneo\u201d General Hospital, 16675 Glyfada, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6354-9805","authenticated-orcid":false,"given":"Ioannis","family":"Georgakopoulos","sequence":"additional","affiliation":[{"name":"1st Department of Radiology, National and Kapodistrian University of Athens, \u201cAretaieion\u201d University Hospital, 11528 Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2082-7323","authenticated-orcid":false,"given":"Vasileios","family":"Kouloulias","sequence":"additional","affiliation":[{"name":"Department of Clinical Radiation Oncology, Medical School, National and Kapodistrian University of Athens, \u201cAttikon\u201d University Hospital, 12462 Haidari, Greece"},{"name":"Center of Radiation Oncology and Stereotactic Radiosurgery, \u201cMediterraneo\u201d General Hospital, 16675 Glyfada, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,2,17]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.radonc.2017.05.012","article-title":"ESTRO ACROP consensus guideline on implementation and practice of stereotactic body radiotherapy for peripherally located early stage non-small cell lung cancer","volume":"124","author":"Guckenberger","year":"2017","journal-title":"Radiother. Oncol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.prro.2017.04.014","article-title":"Stereotactic body radiation therapy for early-stage non-small cell lung cancer: Executive Summary of an ASTRO Evidence-Based Guideline","volume":"7","author":"Videtic","year":"2017","journal-title":"Pract. Radiat. Oncol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1097\/JTO.0000000000000453","article-title":"Stereotactic ablative radiotherapy for centrally located early stage non-small-cell lung cancer: What we have learned","volume":"10","author":"Chang","year":"2015","journal-title":"J. Thorac. Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.lungcan.2021.07.007","article-title":"Stereotactic ablative radiotherapy in T1-2N0M0 small cell lung cancer: A systematic review and meta-analysis","volume":"160","author":"Safavi","year":"2021","journal-title":"Lung Cancer"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Zygogianni, A., Koukourakis, I.M., Georgakopoulos, J., Armpilia, C., Liakouli, Z., Desse, D., Ntoumas, G., Simopoulou, F., Nikoloudi, M., and Kouloulias, V. (2024). Robotic Stereotactic Ablative Radiotherapy for Patients with Early-Stage Lung Cancer: Results of an Interim Analysis. Cancers, 16.","DOI":"10.3390\/cancers16183227"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"4222","DOI":"10.1002\/cncr.29640","article-title":"Stereotactic body radiation therapy versus no treatment for early stage non-small cell lung cancer in medically inoperable elderly patients: A National Cancer Data Base analysis","volume":"121","author":"Nanda","year":"2015","journal-title":"Cancer"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1080\/0284186X.2017.1374558","article-title":"Survival of localized NSCLC patients without active treatment or treated with SBRT","volume":"57","author":"Jeppesen","year":"2018","journal-title":"Acta Oncol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.radonc.2016.08.015","article-title":"SPACE\u2014A randomized study of SBRT vs. conventional fractionated radiotherapy in medically inoperable stage I NSCLC","volume":"121","author":"Nyman","year":"2016","journal-title":"Radiother. Oncol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/S1470-2045(18)30896-9","article-title":"Stereotactic ablative radiotherapy versus standard radiotherapy in stage 1 non-small-cell lung cancer (TROG 09.02 CHISEL): A phase 3, open-label, randomised controlled trial","volume":"20","author":"Ball","year":"2019","journal-title":"Lancet Oncol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1001\/jamaoncol.2024.3089","article-title":"Stereotactic vs. Hypofractionated Radiotherapy for Inoperable Stage I Non-Small Cell Lung Cancer: The LUSTRE Phase 3 Randomized Clinical Trial","volume":"10","author":"Swaminath","year":"2024","journal-title":"JAMA Oncol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"4833","DOI":"10.1200\/JCO.2006.07.5937","article-title":"Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer","volume":"24","author":"Timmerman","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1200\/JCO.18.00622","article-title":"Safety and Efficacy of a Five-Fraction Stereotactic Body Radiotherapy Schedule for Centrally Located Non-Small-Cell Lung Cancer: NRG Oncology\/RTOG 0813 Trial","volume":"37","author":"Bezjak","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"107281","DOI":"10.1016\/j.lungcan.2023.107281","article-title":"Stereotactic body radiotherapy for Ultra-Central lung Tumors: A systematic review and Meta-Analysis and International Stereotactic Radiosurgery Society practice guidelines","volume":"182","author":"Yan","year":"2023","journal-title":"Lung Cancer"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Salvestrini, V., Lastrucci, A., Banini, M., Loi, M., Carnevale, M.G., Olmetto, E., Garlatti, P., Simontacchi, G., Francolini, G., and Bonomo, P. (2024). Recent Advances and Current Challenges in Stereotactic Body Radiotherapy for Ultra-Central Lung Tumors. Cancers, 16.","DOI":"10.20944\/preprints202410.1934.v1"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/j.jtho.2024.05.366","article-title":"Stereotactic Body Radiotherapy for Centrally Located Inoperable Early-Stage NSCLC: EORTC 22113-08113 LungTech Phase II Trial Results","volume":"19","author":"Levy","year":"2024","journal-title":"J. Thorac. Oncol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1016\/j.ijrobp.2014.08.008","article-title":"Local. control and toxicity in a large cohort of central lung tumors treated with stereotactic body radiation therapy","volume":"90","author":"Modh","year":"2014","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.adro.2019.01.002","article-title":"Long-term Clinical Outcomes and Safety Profile of SBRT for Centrally Located NSCLC","volume":"4","author":"Arnett","year":"2019","journal-title":"Adv. Radiat. Oncol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"18","DOI":"10.21037\/tro.2019.05.01","article-title":"Stereotactic Ablative Radiotherapy for Central and Ultra-Central Lung Tumors","volume":"3","author":"Chaudhuri","year":"2019","journal-title":"Ther. Radiol. Oncol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"7024","DOI":"10.21037\/jtd-2019-cptn-01","article-title":"Stereotactic body radiotherapy (SBRT) for central and ultracentral node-negative lung tumors","volume":"12","author":"Owen","year":"2020","journal-title":"J. Thorac. Dis."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.ijrobp.2024.04.009","article-title":"Safety and Efficacy of Stereotactic Body Radiation Therapy for Ultra-central Thoracic Tumors: A Single Center Retrospective Review","volume":"120","author":"Li","year":"2024","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.jtho.2021.03.019","article-title":"The HILUS-Trial-a Prospective Nordic Multicenter Phase 2 Study of Ultracentral Lung Tumors Treated With Stereotactic Body Radiotherapy","volume":"16","author":"Lindberg","year":"2021","journal-title":"J. Thorac. Oncol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.ijrobp.2024.03.050","article-title":"Stereotactic Radiation for Ultra-Central Non-Small Cell Lung Cancer: A Safety and Efficacy Trial (SUNSET)","volume":"120","author":"Giuliani","year":"2024","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.chest.2016.10.010","article-title":"The Eighth Edition Lung Cancer Stage Classification","volume":"151","author":"Detterbeck","year":"2017","journal-title":"Chest"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur. J. Cancer"},{"key":"ref_25","unstructured":"Shah, S. (2026, February 12). Common Terminology Criteria for Adverse Events (CTCAE), Available online: https:\/\/dctd.cancer.gov\/research\/ctep-trials\/for-sites\/adverse-events\/ctcae-v5-5x7.pdf."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.lungcan.2020.07.009","article-title":"Analysis of pneumonitis and esophageal injury after stereotactic body radiation therapy for ultra-central lung tumors","volume":"147","author":"Wang","year":"2020","journal-title":"Lung Cancer"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/j.ijrobp.2023.06.246","article-title":"Expanded HILUS Trial: A Pooled Analysis of Risk Factors for Toxicity From Stereotactic Body Radiation Therapy of Central and Ultracentral Lung Tumors","volume":"117","author":"Lindberg","year":"2023","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_28","first-page":"1316","article-title":"Dosimetric Outcomes of Stereotactic Body Radiation Therapy to Ultracentral Lung Tumors: Lessons From the SUNSET Trial","volume":"37","author":"Salunkhe","year":"2025","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.radonc.2022.04.005","article-title":"Thorough design and pre-trial quality assurance (QA) decrease dosimetric impact of delineation and dose planning variability in the STRICTLUNG and STARLUNG trials for stereotactic body radiotherapy (SBRT) of central and ultra-central lung tumours","volume":"171","author":"Hoffmann","year":"2022","journal-title":"Radiother. Oncol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"100746","DOI":"10.1016\/j.iotech.2024.100746","article-title":"117O Stereotactic body radiotherapy (SBRT) with pembrolizumab (pembro) for unresected stage I\/II non-small cell lung cancer (NSCLC): The randomized, double-blind, phase III KEYNOTE-867 study","volume":"24","author":"Pircher","year":"2024","journal-title":"Immuno-Oncol. Technol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1200\/JCO.20.00818","article-title":"Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastatic Cancers: Long-Term Results of the SABR-COMET Phase II Randomized Trial","volume":"38","author":"Palma","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1136\/thoraxjnl-2013-204528","article-title":"Pulmonary metastasectomy: What is the practice and where is the evidence for effectiveness?","volume":"69","author":"Treasure","year":"2014","journal-title":"Thorax"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.21037\/jtd.2020.04.28","article-title":"The epidemiology and biology of pulmonary metastases","volume":"13","author":"Gerull","year":"2021","journal-title":"J. Thorac. Dis."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"107284","DOI":"10.1016\/j.lungcan.2023.107284","article-title":"Stereotactic Body Radiotherapy for Lung Oligo-metastases: Systematic Review and International Stereotactic Radiosurgery Society Practice Guidelines","volume":"182","author":"Mayinger","year":"2023","journal-title":"Lung Cancer"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"e173501","DOI":"10.1001\/jamaoncol.2017.3501","article-title":"Consolidative Radiotherapy for Limited Metastatic Non-Small-Cell Lung Cancer: A Phase 2 Randomized Clinical Trial","volume":"4","author":"Iyengar","year":"2018","journal-title":"JAMA Oncol."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Zygogianni, A., Koukourakis, I.M., Liakouli, Z., Desse, D., Georgakopoulos, I., Armpilia, C., Lymperopoulou, G., and Kouloulias, V. (2025). Low-Burden Oligometastatic Disease of the Lung Treated with Robotic Stereotactic Ablative Radiotherapy: A Retrospective Study. Biomedicines, 13.","DOI":"10.3390\/biomedicines13020517"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Liu, X., and Chi, A. (2023). Combining stereotactic body radiotherapy with immunotherapy in stage IV non-small cell lung cancer. Front. Oncol., 13.","DOI":"10.3389\/fonc.2023.1211815"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1093\/jnci\/djac015","article-title":"Randomized Trial of First-Line Tyrosine Kinase Inhibitor With or Without Radiotherapy for Synchronous Oligometastatic EGFR-Mutated Non-Small Cell Lung Cancer","volume":"115","author":"Wang","year":"2023","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"104520","DOI":"10.1016\/j.critrevonc.2024.104520","article-title":"Combined use of radiotherapy and tyrosine kinase inhibitors in the management of metastatic non-small cell lung cancer: A literature review","volume":"204","author":"Georgakopoulos","year":"2024","journal-title":"Crit. Rev. Oncol. Hematol."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/4\/653\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T09:10:25Z","timestamp":1772010625000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/4\/653"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,17]]},"references-count":39,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,2]]}},"alternative-id":["cancers18040653"],"URL":"https:\/\/doi.org\/10.3390\/cancers18040653","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,17]]}}}